Información de la revista
Vol. 105. Núm. 2.
Páginas 178-185 (marzo 2014)
Visitas
11368
Vol. 105. Núm. 2.
Páginas 178-185 (marzo 2014)
Original Article
Acceso a texto completo
Skin Disorders in Overweight and Obese Patients and Their Relationship With Insulin
Dermatosis en pacientes con sobrepeso y obesidad y su relación con la insulina
Visitas
11368
A. Plascencia Gómeza,
Autor para correspondencia
dontol@hotmail.com

Corresponding author.
, M.E. Vega Memijeb, M. Torres Tamayoc, A.A. Rodríguez Carreónb
a Centro Dermatológico de Yucatan Mérida, Yucatán, Mexico
b Servicio de Dermatología, Hospital General Dr. Manuel Gea González, Mexico DF, Mexico
c Servicio de Endocrinología, Hospital General Dr. Manuel Gea González, Mexico DF, Mexico
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (5)
Mostrar másMostrar menos
Tablas (5)
Table 1. Clinical and Biochemical Characteristics According to Overweight and the Grade of Obesitya
Table 2. Frequency of Diseases Associated With Overweight and Grade of Obesitya
Table 3. Frequency of Skin Disorders and Number of Skin Tags According to Overweight and the Grade of Obesitya
Table 4. Median Values of Insulin and HOMA-IR and Number of Skin Tags According to the Grade of Acanthosis on the Necka
Table 5. Ordinal Regression Analysis to Evaluate the Independence of the Association Between Insulin and the Grade of Acanthosis and the Number of Skin Tagsa
Mostrar másMostrar menos
Abstract
Introduction

The prevalence of obesity has increased worldwide in recent years. Some authors have described skin conditions associated with obesity, but there is little evidence on the association between insulin levels and such disorders.

Objective

To describe the skin disorders present in overweight and obese patients and analyze their association with insulin levels.

Material and methods

The study included nondiabetic male and female patients over 6 years of age who were seen at our hospital between January and April 2011. All the patients were evaluated by a dermatologist, who performed a physical examination, including anthropometry, and reviewed their medical history and medication record; fasting blood glucose and insulin were also measured. The patients were grouped according to degree of overweight or obesity and the data were compared using analysis of variance or the χ2 test depending on the type of variable. The independence of the associations was assessed using regression analysis.

Results

In total, 109 patients (95 adults and 13 children, 83.5% female) were studied. The mean (SD) age was 38 (14) years and the mean body mass index was 39.6±8kg/m2. The skin conditions observed were acanthosis nigricans (AN) (in 97% of patients), skin tags (77%), keratosis pilaris (42%), and plantar hyperkeratosis (38%). Statistically significant associations were found between degree of obesity and AN (P=.003), skin tags (P=.001), and plantar hyperkeratosis. Number of skin tags, AN neck severity score, and AN distribution were significantly and independently associated with insulin levels.

Conclusions

AN and skin tags should be considered clinical markers of hyperinsulinemia in nondiabetic, obese patients.

Keywords:
Obesity
Dermatosis
Insulin
Acanthosis nigricans
Skin tags
Resumen
Introducción

La prevalencia de obesidad se ha incrementado mundialmente en los últimos años. Existen estudios que describen las dermatosis que se asocian con la obesidad; sin embargo, existe poca evidencia de su asociación con los niveles de insulina.

Objetivo

Describir las dermatosis presentes en pacientes con sobrepeso y obesidad y su asociación con los niveles de insulina.

Material y métodos

Se incluyeron pacientes de ambos sexos, mayores de 6 años, no diabéticos que acudieron a la consulta durante los meses de enero a abril de 2011. Todos los sujetos fueron valorados por un dermatólogo, se realizó exploración física, antropometría, historia médica, medicamentos y medición de glucosa e insulina de ayuno. Los pacientes se dividieron de acuerdo a sobrepeso y grado de obesidad y se compararon con Anova o Chi cuadrado, dependiendo del tipo de variable. Se realizó análisis de regresión para evaluar la independencia de las asociaciones.

Resultados

Fueron incluidos 109 pacientes (95 adultos y 13 niños; 83,5% mujeres), con edad media de 38±14 años y un índice de masa corporal de 39,6±8kg/m2. Las dermatosis encontradas fueron: acantosis nigricans (97%), fibromas (77%), queratosis pilar (42%) e hiperqueratosis plantar (38%). Las que se asociaron de forma estadísticamente significativa con el grado de obesidad fueron acantosis nigricans (p=0,003), fibromas (p=0,001) e hiperqueratosis plantar. El grado de acantosis nigricans en el cuello, su topografía y el número de fibromas mostraron asociación significativa e independiente con los niveles de insulina.

Conclusiones

La acantosis y los fibromas deberían considerarse marcadores clínicos de hiperinsulinemia en población obesa y no diabética.

Palabras clave:
Obesidad
Dermatosis
Insulina
Acantosis nigricans
fibromas
Texto completo
Introduction

The last 3 decades have seen an unprecedented increase in the prevalence of obesity throughout the world.1 In the United States of America, the prevalence of obesity is 35.5% in men, 35.8% in women,2 and 17% in children aged 2 to 19 years.3 In Mexico, the 2012 National Health Survey reported that the prevalence of obesity (body mass index [BMI]30kg/m2) in adults was 32.4% and the prevalence of overweight was 38.8% and that this prevalence was higher in women (37.5%) than in men (26.8%). The combined prevalence of overweight and obesity is only 3.6 percentage points greater in women (73.0%) than in men (69.4%); the combined prevalence for adolescents and adolescent males was 35.8% and 34.1%, respectively.4 Although obesity is considered a public health problem, it was recently recognized that rapid multidisciplinary action is necessary to ensure better prevention, timely diagnosis, and control.5,6 Obesity is accompanied by comorbid conditions such as hypertension, type 2 diabetes mellitus, cardiovascular disease, polycystic ovary syndrome, obstructive sleep apnea syndrome, breast and colorectal cancer, psychological and orthopedic problems, and skin disorders.7

Dermatologic manifestations associated with obesity are common8,9 and have been classified according to their pathophysiologic origin as being associated with insulin resistance (IR), hyperandrogenism, skin folds, mechanical causes, and hospitalization.10,11 Several publications have shown the association between IR and acanthosis nigricans (AN) and skin tags both in adults12 and in children.13,14 The objectives of the present study were to identify skin disorders associated with obesity and to evaluate the correlation between insulin concentrations and skin disorders in nondiabetic overweight or obese individuals.

Materials and Methods

We performed an analytical cross-sectional study including patients aged >6 years (patients aged >18 years were considered adults) of both sexes who attended the Obesity Clinic (bariatric surgery) and the Nutrition Clinic of Hospital General Dr. Manuel Gea González, Mexico City, Mexico from January to April 2011. All patients included in the study signed the informed consent document. All patients who were invited to participate agreed to do so. The Obesity Clinic handles patients who are candidates for bariatric surgery (BMI>40kg/m2 or>35kg/m2 accompanied by a comorbid condition). The Nutrition Clinic handles overweight and obese patients referred from other hospital departments. Patients with diabetes mellitus, pregnant women, and patients taking corticosteroids for more than 3 weeks were excluded, since each of these clinical conditions can be accompanied by specific skin disorders. Patients underwent a physical examination, and their clinical history was taken, with emphasis on previous diseases and anthropometric data (weight, height, waist circumference, and hip circumference). The skin examination aimed to identify lesions associated with hyperinsulinemia, namely, presence and degree of AN on the neck, AN at other sites, and presence and number of skin tags. The examination also included skin disorders associated with hyperandrogenism (acne, hirsutism, and androgenic alopecia), skin folds (intertrigo and bacterial complications), and mechanical causes (striae, lipodystrophy, plantar hyperkeratosis, and venous insufficiency). AN on the neck was graded according to the classification proposed by Burke et al.15: grade 0, absent; grade 1, detectable only on close visual inspection; grade II, <7.6cm in length (limited to the base of the skull); grade III, 7.6-15.2cm (extending to the lateral margins of the neck); and grade IV, >15.2cm (takes the form of a “collar” when viewed from the front). Fasting glucose and insulin (8h) were measured. Prediabetes was defined as fasting glucose of 100-125mg/dL and diabetes as fasting glucose >126mg/dL on at least 2 symptom-free occasions. BMI was calculated using the Quetelet formula (weight inkg divided by height inm2); the homeostasis model assessment of insulin resistance (HOMA-IR) was calculated using the formula glucose in mmol/dL multiplied by insulin in μUI/mL divided by the constant 22.5.16 IR was defined arbitrarily as a HOMA-IR3. The World Health Organization classification was used for overweight and obesity both in children (2-18 years) and in adults (>18 years). In adults, overweight was defined as a BMI of 25-29.9, grade I obesity as a BMI of 30-34.9, grade II obesity as a BMI of 35-39.9, and grade III obesity as a BMI>40.17 In children, overweight was defined as a BMIthe 85th percentile and lower than the 95th percentile, obesity as a BMIthe 95th percentile, and severe obesity as a BMI>the 99th percentile.18 Hypercholesterolemia was defined as total cholesterol 200mg/dL, hypertriglyceridemia as triglycerides150mg/dL, hypoalfalipoproteinemia as high-density lipoprotein cholesterol<40mg/dL, and IR as a HOMA-IR index3.

The study protocol was approved by the local ethics committee.

Statistical Analysis

Patients were divided into 4 groups according to the presence of overweight and the degree of obesity. Quantitative variables were compared using parametric or nonparametric tests. The frequency of skin disorders was compared using the χ2 test for trend. Insulin concentrations were correlated with the grade of AN and the number of skin tags using the Spearman rank correlation coefficient. Multiple regression analysis was performed to evaluate the independence of the association between insulin and the number of skin tags; ordinal logistic regression was performed to evaluate the independence of the association between insulin and the grade of AN. Age, sex, and BMI were taken into consideration in both models. Statistical significance was set at P<.05. The analysis was performed using SPSS, version 19.0.

Results

Our study included 109 patients (91 women [83.5%] and 18 men; 96 adults and 13 children). The mean (SD) values were as follows: age, 38 (14) years (range, 8-69 years); weight, 104 (26) kg; BMI, 39.6 (8); waist circumference, 117 (19) cm; and waist-hip index, 0.9 (0.08). About half of the patients (54 [49.5%]) met the criteria for grade III obesity. Patients with grade I obesity were significantly younger than those with grade II obesity (28.3 [15.4] vs 46.8 [11] years; P>.001). Significant differences were recorded for glucose, insulin, and the HOMA-IR index between the different grades of obesity (Table 1).

Table 1.

Clinical and Biochemical Characteristics According to Overweight and the Grade of Obesitya

Variable  Total (N=109)  Overweight (n=109)  ObesityP 
      Grade I (n=20)  Grade II (n=25)  Grade III (n=54)   
Age, y  38±14  34.7±20.7  28.3±15.4  46.8±11  38.2±11  .000 
Weight, kg  104±26  60.2±1 2.9  89±21  95±10  122±20  .000 
Height, cm  161±8.3  150.8±6.2  159±8.1  160±7.3  164±7.4  .000 
BMI, kg/m2  39.6±26±36±37±1.4  45±5.4  0.000 
Waist, cm  117±19  92±107±15  114±19  119±13  .000 
WCI  0.9±0.08  0.9±0.06  0.9±0.06  0.8±0.06  0.9±0.09  .103 
Glucose, mg/dL  95±10  92±87±96±12  98±10  .001 
Insulin, μIU/mL  19±10  7±14±13±27±10  .000 
HOMA-IR  4.6±2.7  1.6±1.4  3±3.1±6±.000 

Abbreviations: BMI, body mass index; HOMA-IR, homeostasis model assessment of insulin resistance; WCI, waist-circumference index.

a

Data are expressed as mean (SD). The P value was calculated using an analysis of variance.

The frequency of prediabetes was 38.5%, which was greater in the grade III group (57.4%); this group also had a significantly greater frequency of IR (81.5%) than the overweight and grades I and II groups. The overweight group had 2 cases for which glucose values were compatible with a diagnosis of prediabetes, although no other comorbid conditions were recorded. No differences were recorded between the groups in the frequency of hypothyroidism, high total cholesterol and triglycerides, or low HDL cholesterol according to the grade of obesity (Table 2).

Table 2.

Frequency of Diseases Associated With Overweight and Grade of Obesitya

Disease, No. (%)  Total (N=109)  Overweight (n=10)  ObesityP 
      Grade I (n=20)  Grade II (n=25)  Grade III (n=54)   
Hypothyroidism  16 (14.7)  1 (5)  5 (20)  10 (18.5)  .378 
Hypercholesterolemia  35 (32)  5 (25)  9 (36)  21 (38.9)  .089 
Hypertriglyceridemia  40 (37)  7 (35)  9 (36)  24 (44.4)  .065 
Hypoalfaproteinemia  18 (16.5)  5 (25)  4 (16)  9 (16.7)  .387 
Prediabetes  42 (38.5)  2 (20)  1 (5)  8 (32)  31 (57.4)  .000 
POS  4 (3.7)  4 (7.4)  .238 
IR (HOMA-IR>3)  64 (66.7)  9 (47.4)  11 (52.4)  44 (81.5)  .000 

Abbreviations: HOMA-IR, homeostasis model assessment of insulin resistance; IR, insulin resistance; POS, polycystic ovary syndrome.

a

Data are expressed as frequency (%). The P value was calculated using the χ2 test.

The frequency of skin disorders (Table 3) was as follows: AN, 97%; skin tags, 77%; keratosis pilaris, 42%; plantar hyperkeratosis, 38%; xerosis, 34%; and striae, 28%. The least frequent were palmoplantar hyperhidrosis (9%), hirsutism (5%), gynecomastia (3%), and intertrigo (1%). No acne lesions were recorded. When the frequency of these skin disorders was compared according to the presence of overweight and grade of obesity, statistically significant differences were found for AN, skin tags, plantar hyperkeratosis, and striae. With the exception of striae, the frequency of the remaining skin disorders mentioned increased with the grade of obesity.

Table 3.

Frequency of Skin Disorders and Number of Skin Tags According to Overweight and the Grade of Obesitya

Skin disorder, n (%)  AllN=109  Overweightn=10  ObesityP 
      Grade I(n=20)n=15  Grade II(n=25)n=25  Grade III(n=54)n=44   
Acanthosis nigricans  106 (97)  6 (60)  19 (95)  25 (100)  54 (100)  .003 
Skin tags  84 (77)  5 (50)  10 (50)  21 (84)  48 (88.9)  .001 
Hyperkeratosis  42 (38.5)  5 (25)  7 (28)  30 (55.6)  ND 
Striae    7 (35)  4 (16)  20 (37)  ND 
Hirsutism  6 (5.6)  4 (16)  2 (3.7)  ND 
Keratosis pilaris  46 (42.2)  4 (40)  10 (50)  8 (32)  24 (44.4)  ND 
Xerosis  37 (33.9)  5 (50)  7 (35)  7 (28)  18 (33.3)  .668 
Venous insufficiency  19 (17.4)  3 (15)  7 (28)  9 (16.7)  ND 
Hyperhidrosis  10 (9.2)  1 (5)  1 (4)  8 (14.8)  ND 
Onychocryptosis  20 (18.3)  4 (20)  4 (16)  12 (22.2)  ND 
Dermatophytosis  20 (18.3)  3 (15)  4 (16)  13 (24.1)  ND 
Other  24 (22.0)  3 (30)  4 (20)  4 (16)  13 (24.1)  ND 
Number of skin tags  18 (7-18)  4 (3-4)  4.5 (4-6)  11 (7-19)  24 (14-35)  .000 

Abbreviation: ND, not determined.

a

Data are expressed as simple frequency (percentage). The P value was calculated using the χ2 statistic, which was not determined when the value of the cell was less than 5. The number of skin tags is expressed as median (interquartile range) and was compared using the Kruskal-Wallis test.

Analysis of the grade of AN on the neck revealed that 80% of overweight patients did not have AN (40%) or that AN was visible only at close inspection (40%), whereas 61% of the grade III group had grade 4 AN (Fig. 1). Acanthosis was present in all patients with grades II and III obesity. Similarly, more sites were affected in patients with grade III obesity (Fig. 2), and the percentage of persons with IR increased with the grade of AN on the neck (Fig. 3). The average values for insulin, HOMA-IR, and number of skin tags increased with the grade of AN on the neck (Table 4).

Figure 1.

Frequency (%) of the grade of AN on the neck according to overweight and grade of obesity. AN indicates acanthosis nigricans; G, grade.

(0.09MB).
Figure 2.

Frequency (%) of AN on the neck, axillas, knuckles, and submammary region according to overweight and degree of obesity. AN indicates acanthosis nigricans; G, grade.

(0.1MB).
Figure 3.

Frequency of insulin resistance according to the grade of acanthosis on the neck. G indicates grade; HOMA-IR, homeostasis model assessment of insulin resistance. The P value was calculated using the χ2 test for trend.

(0.08MB).
Table 4.

Median Values of Insulin and HOMA-IR and Number of Skin Tags According to the Grade of Acanthosis on the Necka

  No Acanthosis  Grade I  Grade II  Grade III  Grade IV  P 
Insulin, μU/mL  6.9±1.81  9.5±4.5  15.1±6.9  18.7±7.2  26.9±12.0  .0001 
HOMA-IR  1.61±0.6  2.1±1.0  3.8±1.9  4.4±1.9  6.5±3.0  .0001 
No. of skin tags  3±6±9±17±30±16  .0001 

Abbreviation: HOMA-IR, homeostasis model assessment of insulin resistance.

a

Data are expressed as mean (SD). The P value was calculated using the Kruskal-Wallis test.

The correlation detected between the number of skin tags and insulin levels (r=0.665; P<.005) remained significant after adjustment for age, sex, and BMI (Fig. 4). Multiple and ordinal regression analysis confirmed the independence of the association between insulin levels and the grade of AN and the association between insulin levels and the number of skin tags, respectively (Table 5).

Figure 4.

Spearman correlation analysis of insulin levels with the number of skin tags in patients with overweight and obesity.

r indicates the Spearman correlation coefficient; ra, the correlation coefficient adjusted for age, sex, and body mass index.

(0.07MB).
Table 5.

Ordinal Regression Analysis to Evaluate the Independence of the Association Between Insulin and the Grade of Acanthosis and the Number of Skin Tagsa

  Nonstandardized CoefficientsStandardized Coefficients  P 
  Standard Error  Beta     
Grade of acanthosis
Constant  −0.321  0.769  −0.417    .678 
Insulin  0.768  0.131  0.612  5.882  .000 
Age  −1.995E-02  0.007  −0.229  −3.011  .003 
Sex  −0.112  0.245  −0.035  −0.457  .648 
BMI  0.103  0.012  0.663  8.600  .000 
Prediabetes  −0.037  0.200  −0.015  −0.188  .852 
No. of skin tags
Constant  −23.103  10.932    −2.113  .038 
Insulin  0.768  0.131  0.612  5.882  .000 
Age  0.161  0.121  0.123  1.326  .189 
Sex  3.449  3.694  0.083  0.934  .354 
BMI  0.387  0.225  0.179  1.720  .090 

Abbreviation: BMI, body mass index.

a

In the first model, age, sex, BMI, and prediabetes were added; in the second, age, sex, and BMI were added.

Discussion

AN was the most frequent skin disorder in the overweight and obese patients we studied (97%). This finding is consistent with data reported elsewhere.19–21 The presence of AN was directly proportional to the grade of obesity19,20 and was associated with high blood levels of insulin.21 AN is considered a skin marker of IR and hyperinsulinism. A high insulin concentration leads to direct activation of insulin receptors and activation in dermal fibroblasts and keratinocytes via insulinlike growth factor 1, thus promoting their proliferation.22 AN is observed mainly in the axilla, groin, and neck, although it can also appear under the breasts and on the knuckles, elbows, and face.9 In the study group, AN was more disseminated and severity of AN on the neck increased with the grade of obesity. Although several authors confirm the association between AN and IR13,23,24 and AN and high levels of insulin,15 in Mexico, 2 studies have evaluated skin disorders in obese patients. The first was performed by García-Hidalgo et al.10 and included 156 obese patients (80% women), 48.7% of whom had diabetes and 29.5% AN. The second was performed by García-Solis et al.20 and included a large number of patients (3293 [age 15 to 40 years; 59.4% women], of whom 64.8% were overweight, 19% had grade I obesity, 9.6% grade II obesity, and 6% grade III obesity). The authors found that 1284 patients (38.9%) had obesity-associated skin disorders and that 14% had AN. The differences between the 2 Mexican populations cited and ours are clear, especially for age and grade of obesity. The selection bias arises because most of the patients we included attended the obesity clinic to undergo bariatric surgery; therefore, the grade of obesity was higher in our population. Also important is the observation that the patients were generally from a low or very low socioeconomic stratum, and this could be associated with having a skin phototype of IV or V, which can play a role in the manifestation of AN.21 Insulin levels were not determined in either of the 2 Mexican study populations.10,20 Hud et al.21 found AN in 74% of 34 obese individuals, most of whom were black.

Skin tags were detected in 77% of the patients included in our study, whereas in that of García-Hidalgo et al.10 they were detected in 44.2% of patients and in 50% of diabetic patients; in the study by García-Solis et al.,20 skin tags were only detected in 9.9% of patients. Skin tags are the second most common skin disorder in obese patients, and, as with AN, they are also directly associated with the grade of obesity19,20 and high insulin levels.15,19,25 Rasi et al.26 found that diabetes mellitus was more common in patients with skin tags and that having more than 30 skin tags considerably increased the risk of diabetes.26 Although one of the exclusion criteria was presence of type 2 diabetes mellitus, a high frequency of prediabetes (38.5%) and IR (66.7%) was detected in the study population. Insulin concentrations increased with the grade of AN on the neck, as did the number of skin tags and the HOMA-IR index (Figs. 3 and 4). Guida et al.19 found that skin tags, plantar hyperkeratosis, AN, striae, intertrigo, hyperhidrosis, and keratosis pilaris were directly proportional to the grade of obesity. Except for keratosis pilaris, similar findings were observed in our study (Fig. 5).

Figure 5.

Woman aged 45 years with grade III obesity and grade IV acanthosis nigricans on the neck.

(0.1MB).

Follicular keratosis or keratosis pilaris was found in 42.1% of patients, with no differences between the groups according to the grade of obesity. Although keratosis pilaris is more associated with atopy, it is also observed in obese patients, especially in those with a higher BMI,9,27 suggesting that high insulin levels and IR play an important role in its etiology.

Plantar hyperkeratosis was observed in 38.5% of cases, although in patients with grade III obesity, this figure increased to 55.6%, which was lower than that reported by some authors (80%)19 and higher than that found by others (34.6%).10 This skin disorder is more common in individuals aged over 60 years20 and should be considered a visible sign of severe obesity.8

Striae have been reported in 80% of patients with grade III obesity.19 However, in our study, they affected 37% of this group. The exact pathogenic mechanism of striae is unclear, although they could be considered scars resulting from damage to the collagen fibers of the dermal connective tissue followed by formation of new fibers with a lower capacity for support.9 The whitish striae associated with obesity were not correlated with insulin levels and were recorded in 28.4% of patients.

Xerosis was present in 34% of the study patients, although no association was established with grade of obesity; in the study by Brown et al.,8 67% of the patients were affected. Xerosis is associated with deficiency in humectants (collectively known as natural moisturizing factor), ceramides, and humectant modulated by aquaporin water channels.26–28

Venous insufficiency can worsen with obesity owing to increased abdominal pressure, which limits deep venous return in the legs.9 Moreover, delayed vasodilation after occlusion in obese patients29 could lead to venous insufficiency. The frequency of this disorder in our sample was 17.4%.

Intertrigo has also been associated with grade of obesity because of the increase in the number of skin folds and the prolonged and occlusive contact of skin with skin, friction, and accumulation of sweat, which is accompanied by increased pH, maceration, and, frequently, overpopulation of microorganisms on the skin surface.9 However, we only found 1 case, probably because of the cold climate of Mexico City and the period of the year when the study was performed (January to April).

Excessive production of androgens by the ovaries (theca cells) is associated with hyperinsulinemia, which is a consequence of IR. Hyperandrogenism leads to acne, hirsutism, and menstrual disorders. In our study population, polycystic ovary syndrome was recorded in 4 patients, hirsutism in 6, and pilar hyperkeratosis, which has also been associated with increased androgen levels,30 in 42.2%. However, none of the patients had acne lesions.

When the groups were evaluated according to overweight and grade of obesity, the statistically significant skin disorders were AN, skin tags, plantar hyperkeratosis, and striae. The grade of AN on the neck was significantly associated with blood insulin levels and IR (defined as a HOMA-IR index>3). Similar findings were recorded for anatomical site: the higher the grade of obesity, the more sites were affected (neck, axillas, intermammary region, and knuckles in patients with grade III obesity). Similarly, a statistically significant association was observed between the number of skin tags and the grade of obesity and insulin levels. The association between insulin levels and grade of AN varied with the inclusion of age in the model (the lower the age, the higher the grade) and BMI (the higher the BMI, the higher the grade). These observations agree with reports from the pediatric population, where it was shown that BMI accounts for 41% of the variance in insulin sensitivity (measured using the clamp technique) and AN accounts for only 4% of the variance.31 On the other hand, the independent association between serum insulin levels and the number of skin tags did not change with the inclusion of age, sex, and BMI in the model.

Although obesity is recognized as a public health problem, its impact on the skin has received little attention. Obesity is responsible for various changes in the physiology of the skin, which can lead to a wide range of skin diseases or worsening of existing skin disorders. With the increase in the number of obese patients, dermatologists must adapt and improve current local and systemic therapy and work with primary care physicians to reduce the deleterious effects of obesity on the skin.

Conclusions

Ours is the first prospective study in Mexico and Latin America to report the association between insulin levels and grade of AN on the neck and number of skin tags in a selected population of overweight and obese patients. Although other studies have shown that AN improves significantly with increased sensitivity to insulin and reduced weight, skin tags have to be treated by a dermatologist.

The presence of AN on the neck and skin tags in an overweight or obese person are easily identifiable clinical signs that could point to hyperinsulinemia secondary to IR. General practitioners, internists, and pediatricians should consider AN as a warning sign urging them to make a deliberate search for abnormalities associated with hyperinsulinemia, such as increased blood sugar, dyslipidemia, and hypertension.

Ethical DisclosuresProtection of human and animal subjects

The authors declare that no experiments were performed on humans or animals for this investigation.

Confidentiality of data

The authors declare that they have followed their hospital's protocol on the publication of data concerning patients and that all patients included in the study have received sufficient information and have given their written informed consent to participate in the study.

Right to privacy and informed consent

The authors declare that no private patient data are disclosed in this article.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

References
[1]
T. Kelly, W. Yang, C.S. Chen, K. Reynolds, J. He.
Global burden of obesity in 2005 and projections to 2030.
Int J Obes (Lond), 32 (2008), pp. 1431-1437
[2]
K.M. Flegal, M.D. Carroll, C.L. Ogden, L.R. Curtin.
Prevalence and trends in obesity among US adults 1999-2008.
JAMA, 303 (2010), pp. 235-241
[3]
C.L. Ogden, M.D. Carroll, L.R. Curtin, M.M. Lamb, K.M. Flegal.
Prevalence of high body mass index in US children and adolescents, 2007-2008.
JAMA, 303 (2010), pp. 242-249
[4]
Encuesta Nacional de Salud y Nutricion 2012. Mexico, diciembre 2012. Available at: http://ensanut.insp.mx
[5]
S. Barquera, J. Rivera, I. Campos-Nonato, L. Hernández-Barrera, C. Santos-Burgoa, E. Durán, et al.
Bases técnicas del acuerdo nacional para la salud alimentaria. Estrategia contra el sobrepeso y la obesidad.
Secretaría de Salud, (2010),
[6]
WHO.
Recommendations on the marketing of foods and non-alcoholic beverages to children.
Prevention and control of noncommunicable diseases: implementation of the global strategy. Sixty-third World Health Assembly, (2010),
[7]
D.P. Guh, W. Zhang, N. Bansback, Z. Amarsi, C.L. Birmingham, A.H. Anis.
The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis.
BMC Public Health, 9 (2009), pp. 88
[8]
J. Brown, P. Wimpenny, H. Maughan.
Skin problems in people with obesity.
[9]
Y. Gil, A. DeVore, A. Dawn.
Obesity and the skin: Skin physiology and skin manifestations of obesity.
J Am Acad Dermatol, 56 (2007), pp. 901-916
[10]
L. García-Hidalgo, R. Orozco-Topete, J. González Barranco, A.R. Villa, J.J. Dalman, G. Ortiz Pedroza.
Dermatoses in 156 obese adults.
Obes Res, 7 (1999), pp. 299-302
[11]
L. Garcia-Hidalgo.
Dermatological complications of obesity.
Am J Clin Dermatol, 3 (2002), pp. 497-506
[12]
G. Sadeghian, H. Ziaie, M. Amini, M. Ali Nilfroushzadeh.
Evaluation of insulin resistance in obese women with and without acanthosis nigricans.
J Dermatol, 36 (2009), pp. 209-212
[13]
H. Yamazaki, S. Ito, H. Yoshida.
Acanthosis nigricans is a reliable cutaneous marker of insulin resistance in obese Japanese children.
Pediatr Int, 45 (2003), pp. 701-705
[14]
K. Copeland, K. Pankratz, V. Cathey, P. Immohotichey, J. Maddox, B. Felton, et al.
Acanthosis nigricans, insulin resistance (HOMA) and dyslipidemia among native American children.
J Okla State Med Assoc, 99 (2006), pp. 19-24
[15]
J.P. Burke, D.E. Hale.
A quantitative scale of acanthosis nigricans.
Diabetes Care, 22 (1999), pp. 1655-1660
[16]
D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner.
Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
Diabetologia, 28 (1985), pp. 412-419
[17]
Norma Oficial Mexicana NOM-008-SSA3-2010, para el tratamiento integral del sobrepeso y la obesidad. Agosto 2010. Available at: http://www.dof.gob.mx
[18]
S.E. Barlow, Expert Committee.
Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary, report.
Pediatrics, 120 (2007), pp. S164-S192
[19]
B. Guida, M. Nino, N.R. Perrino, R. Laccetti, R. Trio, S. Labella, et al.
The impact of obesity on skin disease and epidermal permeability barrier status.
J Eur Acad Dermatol Venereol, 24 (2010), pp. 191-195
[20]
O. García-Solís, D.E. Medina-Castillo, J. de la Cruz-López, S. Huerta-Alvarado, I. Díaz Guadarrama, F. Velázquez-Canchola, et al.
Obesidad y dermatosis: estudio prospectivo y descriptivo en la clínica de consulta externa Alfredo del Mazo Vélez del ISSEMyM Toluca.
Dermatología Rev Mex, 54 (2010), pp. 3-9
[21]
J.A. Hud Jr., J.B. Cohen, J.M. Wagner, P.D. Cruz.
Prevalence and significance of acanthosis nigricans in an adult obese population.
Arch Dermatol, 128 (1992), pp. 941-944
[22]
P.D. Cruz Jr., J.A. Hud Jr..
Excess insulin binding to insulin-like growth factor receptors: Proposed mechanism for acanthosis nigricans.
J Invest Dermatol, 98 (1992), pp. 82S-85S
[23]
M.L. Stoddart, K.S. Blevins, E.T. Lee, W. Wang, P.R. Blackett, Cherokee Diabetes Study.
Association of acanthosis nigricans with hyperinsulinemia compared with other selected risk factors for type 2 diabetes in Cherokee Indians: the Cherokee Diabetes Study.
Diabetes Care, 25 (2002), pp. 1009-1014
[24]
A.S. Kong, R.L. Williams, M. Smith, A.L. Sussman, B. Skipper, A.C. Hsi, et al.
Acanthosis nigricans and diabetes risk factors: prevalence in young persons seen in southwestern US primary care practices.
Ann Fam Med, 5 (2007), pp. 202-208
[25]
F. Jowkar, A. Fallahi, M.R. Namazi.
Is there any relation between serum insulin and insulin-like growth factor-I in non-diabetic patients with skin tag?.
J Eur Acad Dermatol Venereol, 24 (2010), pp. 73-74
[26]
A. Rasi, R. Soltani-Arabshahi, N. Shahbazi.
Skin tag as a cutaneous marker for impaired carbohydrate metabolism: A case-control study.
Int J Dermatol, 46 (2007), pp. 1155-1159
[27]
G. Yosipovitch, B. Mevorah, J. Mashiach, Y.H. Chan, M. David.
High body mass index, dry scaly leg skin and atopic conditions are highly associated with keratosis pilaris.
Dermatology, 201 (2000), pp. 34-36
[28]
T.M. Weber, M. Kausch, F. Rippke, A.M. Schoelermann, A.W. Filbry.
Treatment of xerosis with a topical formulation containing glyceryl glucoside, natural moisturizing factors, and ceramide.
J Clin Aesthet Dermatol, 5 (2012), pp. 29-39
[29]
R.H. Jones, P.J. Carek.
Management of varicose veins.
Am Fam Physician, 78 (2008), pp. 1289-1294
[30]
J.H. Barth, L.L. Ng, F. Wojnarowska, R.P. Dawber.
Acanthosis nigricans, insulin resistance and cutaneous virilism.
Br J Dermatol, 118 (1988), pp. 613-619
[31]
H.A. Kobaissi, M.J. Weigensberg, G.D. Ball, M.L. Cruz, G.Q. Shaibi, M.I. Goran.
Relation between acanthosis nigricans and insulin sensitivity in overweight Hispanic children at risk for type 2 diabetes.
Diabetes Care, 27 (2004), pp. 1412-1416

Please cite this article as: Plascencia Gómez A, Vega Memije ME, Torres Tamayo M, Rodríguez Carreón AA. Dermatosis en pacientes con sobrepeso y obesidad y su relación con la insulina. Actas Dermosifiliogr. 2014;105:178–185.

Copyright © 2013. Elsevier España, S.L. and AEDV
Descargar PDF
Idiomas
Actas Dermo-Sifiliográficas
Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?